Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Osteopeptide is the English intervention name used for a \"small bone peptide\" preparation in a prospective randomized controlled trial sponsored by Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine for early knee osteoarthritis. The public registry identifies the intervention only as osteopeptides and does not disclose a defined peptide sequence, source material, composition, manufacturer, dosage form, route, or molecular target; it therefore should not be conflated with separately named products such as compound osteopeptide injection. ([chictr.org.cn](https://www.chictr.org.cn/showproj.html?proj=42978))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on osteopeptide.